Dataset Information

Patient self-assessment of hospital pain, mood and health-related quality of life in adults with sickle cell disease.

ABSTRACT:

Introduction

Acute pain is a hallmark of sickle cell disease (SCD) for which frequent hospital admissions may be required, affecting the quality of life of patients.

Objectives

To characterise the relationship between adult patient self-reported sickle cell pain, mood and quality of life during and after hospital admissions.

Design

Longitudinal study across three time-points.

Setting

Secondary care, single specialist sickle cell centre.

Participants

510 adult patients with SCD admitted to hospital daycare or inpatient units.

Outcome measures

Self-assessments of pain, mood and health-related quality of life with health utility (measured on the EQ-5D) on admission, before discharge and at 1-week postdischarge.

Results

Mood, general health and quality of life showed significant steady improvements with reduction of pain in patients with SCD on admission to hospital, before discharge and at 1-week follow-up (p<0.01). Health utility scores derived from the EQ-5D showed a negative association with pain in regression analysis over the three time-points.

Conclusion

Examining health-related quality of life and health utility in relation to pain during hospital admissions is valuable in terms of targeting appropriate psychological interventions within the context of a multidisciplinary approach to managing sickle cell pain. This has implications for healthcare costs.

SUBMITTER: Anie KA

PROVIDER: S-EPMC3391376 | biostudies-literature | 2012

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Patient self-assessment of hospital pain, mood and health-related quality of life in adults with sickle cell disease.

Anie Kofi A KA Grocott Hannah H White Lauren L Dzingina Mendwas M Rogers Gabriel G Cho Gavin G

BMJ open 20120702 4

<h4>Introduction</h4>Acute pain is a hallmark of sickle cell disease (SCD) for which frequent hospital admissions may be required, affecting the quality of life of patients.<h4>Objectives</h4>To characterise the relationship between adult patient self-reported sickle cell pain, mood and quality of life during and after hospital admissions.<h4>Design</h4>Longitudinal study across three time-points.<h4>Setting</h4>Secondary care, single specialist sickle cell centre.<h4>Participants</h4>510 adult ...[more]

PMID: 22761289

Similar Datasets

Project description:Associations of modulators of quality of life (QoL) and survival duration are assessed in the fatal motor neuron disease, Amyotrophic Lateral Sclerosis. Major categories include clinical impression of mood (CIM); physical health; patient social support; and usage of interventions, pharmaceuticals, and supplements. Associations were assessed at p < 0.05 and p < 0.001 significance thresholds using applicable methods (Chi-square, t-test, ANOVA, logistical regression, random forests, Fisher's exact test) within a retrospective cohort of 1585 patients. Factors significantly correlated with positive (happy or normal) mood included family support and usage of bi-level positive airway pressure (Bi-PAP) and/or cough assist. Decline in physical factors like presence of dysphagia, drooling, general pain, and decrease in ALSFRS-R total score or forced vital capacity (FVC) significantly correlated with negative (depressed or anxious) mood (p < 0.05). Use of antidepressants or pain medications had no association with ALS patient mood (p > 0.05), but were significantly associated with increased survival (p < 0.05). Positive patient mood, Bi-PAP, cough assist, percutaneous endoscopic gastrostomy (PEG), and accompaniment to clinic visits associated with increased survival duration (p < 0.001). Of the 47 most prevalent pharmaceutical and supplement categories, 17 associated with significant survival duration increases ranging +4.5 to +16.5 months. Tricyclic antidepressants, non-opioids, muscle relaxants, and vitamin E had the highest associative increases in survival duration (p < 0.05). Random forests, which examined complex interactions, identified the following pharmaceuticals and supplements as most predictive to survival duration: Vitamin A, multivitamin, PEG supplements, alternative herbs, antihistamines, muscle relaxants, stimulant laxatives, and antispastics. Statins, metformin, and thiazide diuretics had insignificant associations with decreased survival.

Dataset Information

Patient self-assessment of hospital pain, mood and health-related quality of life in adults with sickle cell disease.

Introduction

Objectives

Design

Setting

Participants

Outcome measures

Results

Conclusion

Publications

Patient self-assessment of hospital pain, mood and health-related quality of life in adults with sickle cell disease.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets